Toll Free: 1-888-928-9744

Global and Europe Osteoarthritis Pain Drugs Market - Analysis and Outlook to 2022

Published: Aug, 2017 | Pages: 119 | Publisher: EU Research
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report presents a comprehensive overview of the Osteoarthritis Pain Drugs market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Osteoarthritis Pain Drugs industry.

This report focuses Global and Europe market,  including details as following:

Key Players
    Johnson & Johnson (US)
    Pfizer (US)
    GlaxoSmithKline (UK)
    Mylan (US)
    Lilly (US)
    Sanofi (France)
    Abbott Laboratories (US)
    Bayer (Germany)
    Almatica Pharma (US)
    Teva Pharmaceutical Industries (Israel)
    Iroko Pharmaceuticals (US)

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Key Product Type
    By Usage Mode: Oral, Injection, External.
    By Form: Tablets, Ointment, Spray.

Key Applications
    Medical Care
    Personal Care
    Other

 Table of Contents

Global and Europe Osteoarthritis Pain Drugs Market - Analysis and Outlook to 2022
1 Market Outline
    1.1 Research Methodology
        1.1.1 Methodology/Research Approach
            Research Programs/Design
            Market Size Estimation
            Market Breakdown and Data Triangulation
        1.1.2 Data Source
            Secondary Sources
            Primary Sources
        1.1.3 Disclaimer
    1.2 Regulatory Factors
    1.3 End-User Analysis
    1.4 Strategic Benchmarking
    1.5 Industry Chain and Supply Chain
        1.5.1 Osteoarthritis Pain Drugs Industry Chain Structure
            1.5.1.1 R&D
            1.5.1.2 Raw Materials (Components)
            1.5.1.3 Manufacturing Plants
            1.5.1.4 Regional Trading (Import Export and Local Sales)
            1.5.1.5 Online Sales Channel
            1.5.1.6 Offline Channel
            1.5.1.7 End Users
        1.5.2 Osteoarthritis Pain Drugs Manufacturing
            1.5.2.1 Key Components
            1.5.2.2 Assembly Manufacturing
        1.5.3 Consumer Preference
        1.5.4 Behavioral Habits
        1.5.5 Marketing Environment
    1.6 SWOT Analysis
    1.7 Feasibility Analysis
    1.8 Development Trend and Research Conclusion
        1.8.1 Development Trend
        1.8.2 Research Conclusion

2 Global Osteoarthritis Pain Drugs Product Overview
    2.1 Global Osteoarthritis Pain Drugs Market Sales Volume Revenue and Price 2012-2017
    2.2 Osteoarthritis Pain Drugs, by Usage Mode 2012-2017
        2.2.1 Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode 2012-2017
        2.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode 2012-2017
        2.2.3 Global Osteoarthritis Pain Drugs Price by Usage Mode 2012-2017
        2.2.4 Oral
        2.2.5 Injection
        2.2.6 External
    2.3 Osteoarthritis Pain Drugs, by Form 2012-2017
        2.3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Form 2012-2017
        2.3.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Form 2012-2017
        2.3.3 Global Osteoarthritis Pain Drugs Price by Form 2012-2017
        2.3.4 Tablets
        2.3.5 Ointment
        2.3.6 Spray

3 Europe Osteoarthritis Pain Drugs Product Overview
    3.1 Europe Osteoarthritis Pain Drugs Market Sales Volume Revenue and Price 2012-2017
    3.2 Osteoarthritis Pain Drugs, by Usage Mode 2012-2017
        3.2.1 Europe Osteoarthritis Pain Drugs Sales Market Share by Usage Mode 2012-2017
        3.2.2 Europe Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode 2012-2017
        3.2.3 Europe Osteoarthritis Pain Drugs Price by Usage Mode 2012-2017
        3.2.4 Oral
        3.2.5 Injection
        3.2.6 External
    3.3 Osteoarthritis Pain Drugs, by Form 2012-2017
        3.3.1 Europe Osteoarthritis Pain Drugs Sales Market Share by Form 2012-2017
        3.3.2 Europe Osteoarthritis Pain Drugs Revenue Market Share by Form 2012-2017
        3.3.3 Europe Osteoarthritis Pain Drugs Price by Form 2012-2017
        3.3.4 Tablets
        3.3.5 Ointment
        3.3.6 Spray

4 Osteoarthritis Pain Drugs Top Companies Profile
    4.1 Johnson & Johnson (US)
        4.1.1 Johnson & Johnson (US) Company Details and Competitors
        4.1.2 Johnson & Johnson (US) Key Osteoarthritis Pain Drugs Models and Performance
        4.1.3 Johnson & Johnson (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.1.4 Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.2 Pfizer (US)
        4.2.1 Pfizer (US) Company Details and Competitors
        4.2.2 Pfizer (US) Key Osteoarthritis Pain Drugs Models and Performance
        4.2.3 Pfizer (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.2.4 Pfizer (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.3 GlaxoSmithKline (UK)
        4.3.1 GlaxoSmithKline (UK) Company Details and Competitors
        4.3.2 GlaxoSmithKline (UK) Key Osteoarthritis Pain Drugs Models and Performance
        4.3.3 GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.3.4 GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.4 Mylan (US)
        4.4.1 Mylan (US) Company Details and Competitors
        4.4.2 Mylan (US) Key Osteoarthritis Pain Drugs Models and Performance
        4.4.3 Mylan (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.4.4 Mylan (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.5 Lilly (US)
        4.5.1 Lilly (US) Company Details and Competitors
        4.5.2 Lilly (US) Key Osteoarthritis Pain Drugs Models and Performance
        4.5.3 Lilly (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.5.4 Lilly (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.6 Sanofi (France)
        4.6.1 Sanofi (France) Company Details and Competitors
        4.6.2 Sanofi (France) Key Osteoarthritis Pain Drugs Models and Performance
        4.6.3 Sanofi (France) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.6.4 Sanofi (France) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.7 Abbott Laboratories (US)
        4.7.1 Abbott Laboratories (US) Company Details and Competitors
        4.7.2 Abbott Laboratories (US) Key Osteoarthritis Pain Drugs Models and Performance
        4.7.3 Abbott Laboratories (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.7.4 Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.8 Bayer (Germany)
        4.8.1 Bayer (Germany) Company Details and Competitors
        4.8.2 Bayer (Germany) Key Osteoarthritis Pain Drugs Models and Performance
        4.8.3 Bayer (Germany) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.8.4 Bayer (Germany) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.9 Almatica Pharma (US)
        4.9.1 Almatica Pharma (US) Company Details and Competitors
        4.9.2 Almatica Pharma (US) Key Osteoarthritis Pain Drugs Models and Performance
        4.9.3 Almatica Pharma (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.9.4 Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.10 Teva Pharmaceutical Industries (Israel)
        4.10.1 Teva Pharmaceutical Industries (Israel) Company Details and Competitors
        4.10.2 Teva Pharmaceutical Industries (Israel) Key Osteoarthritis Pain Drugs Models and Performance
        4.10.3 Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        4.10.4 Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    4.11 Iroko Pharmaceuticals (US)

5 Osteoarthritis Pain Drugs by Regions 2012-2017
    5.1 Global Osteoarthritis Pain Drugs Sales Market Share by Regions 2012-2017
    5.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Regions 2012-2017
    5.3 Global Osteoarthritis Pain Drugs Price by Regions 2012-2017
    5.4 North America
        5.4.1 United States
        5.4.2 Canada
    5.5 Latin America
        5.5.1 Mexico
        5.5.2 Brazil
        5.5.3 Argentina
        5.5.4 Others in Latin America
    5.6 Europe
        5.6.1 Germany
        5.6.2 United Kingdom
        5.6.3 France
        5.6.4 Italy
        5.6.5 Spain
        5.6.6 Russia
        5.6.7 Netherland
        5.6.8 Others in Europe
    5.7 Asia & Pacific
        5.7.1 China
        5.7.2 Japan
        5.7.3 India
        5.7.4 Korea
        5.7.5 Australia
        5.7.6 Southeast Asia
            5.7.6.1 Indonesia
            5.7.6.2 Thailand
            5.7.6.3 Philippines
            5.7.6.4 Vietnam
            5.7.6.5 Singapore
            5.7.6.6 Malaysia
            5.7.6.7 Others in Southeast Asia
    5.8 Africa & Middle East
        5.8.1 South Africa
        5.8.2 Egypt
        5.8.3 Turkey
        5.8.4 Saudi Arabia
        5.8.5 Iran
        5.8.6 Others in Africa & Middle East

6 GlobalOsteoarthritis Pain Drugs by Players 2012-2017
    6.1 Global Osteoarthritis Pain Drugs Sales Volume Market Share by Brands 2012-2017
    6.2 Global Osteoarthritis Pain Drugs Revenue Share by Brands 2012-2017
    6.3 Global Top Players Osteoarthritis Pain Drugs Key Product Model and Market Performance
    6.4 Global Top Players Osteoarthritis Pain Drugs Key Target Consumers and Market Performance

7 EuropeOsteoarthritis Pain Drugs by Players 2012-2017
    7.1 Europe Osteoarthritis Pain Drugs Sales Volume Market Share by Brands 2012-2017
    7.2 Europe Osteoarthritis Pain Drugs Revenue Share by Brands 2012-2017
    7.3 Europe Top Players Osteoarthritis Pain Drugs Key Product Model and Market Performance
    7.4 Europe Top Players Osteoarthritis Pain Drugs Key Target Consumers and Market Performance

8 Global Osteoarthritis Pain Drugs by Consumer 2012-2017
    8.1 Global Osteoarthritis Pain Drugs Sales Market Share by Consumer 2012-2017
    8.2 Medical Care
    8.3 Personal Care
    8.4 Other
    8.5 Consuming Habit and Preference

9 Europe Osteoarthritis Pain Drugs by Consumer 2012-2017
    9.1 Europe Osteoarthritis Pain Drugs Sales Market Share by Consumer 2012-2017
    9.2 Medical Care
    9.3 Personal Care
    9.4 Other
    9.5 Consuming Habit and Preference

10 Global Osteoarthritis Pain Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    10.5 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)

11 Europe Osteoarthritis Pain Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 Europe Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    11.5 Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)


List of Tables and Figures

    Table Global Osteoarthritis Pain Drugs Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Usage Mode (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode in 2016
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Usage Mode (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode in 2016
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Usage Mode (2012-2017)
    Table Top Players of Oral Osteoarthritis Pain Drugs Products List
    Figure Global Oral Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Injection Osteoarthritis Pain Drugs Products List
    Figure Global Injection Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of External Osteoarthritis Pain Drugs Products List
    Figure Global External Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Form (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Market Share by Form (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Form in 2016
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Form (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by Form (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Form in 2016
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Form (2012-2017)
    Table Top Players of Tablets Osteoarthritis Pain Drugs Products List
    Figure Global Tablets Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Ointment Osteoarthritis Pain Drugs Products List
    Figure Global Ointment Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Spray Osteoarthritis Pain Drugs Products List
    Figure Global Spray Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Market Share by  (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by  in 2016
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by  (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by  in 2016
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Market Share by  (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by  in 2016
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by  (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by  in 2016
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by  (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) by Usage Mode (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales Market Share by Usage Mode (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales Market Share by Usage Mode in 2016
    Table Europe Osteoarthritis Pain Drugs Revenue (Million USD) by Usage Mode (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode in 2016
    Table Europe Osteoarthritis Pain Drugs Price (USD/Pcs) by Usage Mode (2012-2017)
    Table Top Players of Oral Osteoarthritis Pain Drugs Products List
    Figure Europe Oral Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Injection Osteoarthritis Pain Drugs Products List
    Figure Europe Injection Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of External Osteoarthritis Pain Drugs Products List
    Figure Europe External Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) by Form (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales Market Share by Form (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales Market Share by Form in 2016
    Table Europe Osteoarthritis Pain Drugs Revenue (Million USD) by Form (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Revenue Market Share by Form (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by Form in 2016
    Table Europe Osteoarthritis Pain Drugs Price (USD/Pcs) by Form (2012-2017)
    Table Top Players of Tablets Osteoarthritis Pain Drugs Products List
    Figure Europe Tablets Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Ointment Osteoarthritis Pain Drugs Products List
    Figure Europe Ointment Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Spray Osteoarthritis Pain Drugs Products List
    Figure Europe Spray Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) by  (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales Market Share by  (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales Market Share by  in 2016
    Table Europe Osteoarthritis Pain Drugs Revenue (Million USD) by  (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Revenue Market Share by  (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by  in 2016
    Table Europe Osteoarthritis Pain Drugs Price (USD/Pcs) by  (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) by  (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales Market Share by  (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales Market Share by  in 2016
    Table Europe Osteoarthritis Pain Drugs Revenue (Million USD) by  (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Revenue Market Share by  (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by  in 2016
    Table Europe Osteoarthritis Pain Drugs Price (USD/Pcs) by  (2012-2017)
    Table Johnson & Johnson (US) Company Details and Competitors
    Table Johnson & Johnson (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer (US) Company Details and Competitors
    Table Pfizer (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Pfizer (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Pfizer (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline (UK) Company Details and Competitors
    Table GlaxoSmithKline (UK) Key Osteoarthritis Pain Drugs Models and Performance
    Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Mylan (US) Company Details and Competitors
    Table Mylan (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Mylan (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Mylan (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Lilly (US) Company Details and Competitors
    Table Lilly (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Lilly (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Lilly (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Sanofi (France) Company Details and Competitors
    Table Sanofi (France) Key Osteoarthritis Pain Drugs Models and Performance
    Table Sanofi (France) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Sanofi (France) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Abbott Laboratories (US) Company Details and Competitors
    Table Abbott Laboratories (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Bayer (Germany) Company Details and Competitors
    Table Bayer (Germany) Key Osteoarthritis Pain Drugs Models and Performance
    Table Bayer (Germany) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Bayer (Germany) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Almatica Pharma (US) Company Details and Competitors
    Table Almatica Pharma (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Almatica Pharma (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Almatica Pharma (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Teva Pharmaceutical Industries (Israel) Company Details and Competitors
    Table Teva Pharmaceutical Industries (Israel) Key Osteoarthritis Pain Drugs Models and Performance
    Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Iroko Pharmaceuticals (US) Company Details and Competitors
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Share by Regions (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Regions in 2016
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Regions in 2017
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by Regions (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2016
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2017
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Regions (2012-2017)
    Table North America Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table North America Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Figure North America Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Key Players 2012-2017
    Table Global Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2012-2017
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2016
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2017
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Key Players 2012-2017
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by Key Players 2012-2017
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Key Players 2016
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Key Players 2017
    Table Global Top Players Key Product Model and Market Performance
    Table Global Top Players Key Target Consumers and Market Performance
    Table Europe Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Key Players 2012-2017
    Table Europe Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2012-2017
    Figure Europe Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2016
    Figure Europe Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2017
    Table Europe Osteoarthritis Pain Drugs Revenue (Million USD) by Key Players 2012-2017
    Table Europe Osteoarthritis Pain Drugs Revenue Market Share by Key Players 2012-2017
    Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by Key Players 2016
    Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by Key Players 2017
    Table Europe Top Players Key Product Model and Market Performance
    Table Europe Top Players Key Target Consumers and Market Performance
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Consumer (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Consumer in 2016
    Figure Global Medical Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Personal Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Other Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) by Consumer (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales Market Share by Consumer (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales Market Share by Consumer in 2016
    Figure Europe Medical Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Europe Personal Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Europe Other Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions in 2022
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application in 2022
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Usage Mode in 2022
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Form in 2022
    Figure Europe Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Europe Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions in 2022
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application in 2022
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Usage Mode in 2022
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
    Figure Europe Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Form in 2022

 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2960
Multi User - US $5920
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify